The risk of nonalcoholic fatty liver disease in gout patients with frequent flares: a retrospective cohort study

被引:3
|
作者
Si, Ke [1 ]
Chi, Jingwei [1 ]
Xu, Lili [1 ]
Dong, Bingzi [1 ]
Liu, Chuanfeng [1 ]
Chen, Ying [1 ]
Wang, Yangang [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao 266003, Peoples R China
关键词
Adipo-IR; Frequency of gout flares; Gout; Non-alcoholic fatty liver disease; INSULIN-RESISTANCE; ADIPOSE-TISSUE; URIC-ACID; ARTHRITIS; CRITERIA; ATTACKS;
D O I
10.1007/s10067-023-06510-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Nonalcoholic fatty liver disease (NAFLD) is a common chronic disease that is related to high serum uric acid; however, the association between the frequency of gout flares and NAFLD risk remains unclear. This study aimed to investigate whether frequent gout flares were associated with incident NAFLD and analyze the interaction of frequency of gout flares and Adipo-IR on NAFLD in the gout Chinese population. Methods A total of 350 cases of gout patients were enrolled in this retrospective cohort study. Cox proportional hazard regression analyses were performed to determine the association between frequent gout flares and NAFLD during follow-up and analyze the interaction of frequency of gout flares and Adipo-IR on NAFLD. Receiver operating curves (ROC) were plotted to explore the diagnostic value of frequent gout flares and Adipo-IR on the occurrence of NAFLD. Results NAFLD developed in 78 participants (22.3%) during follow-up. Logistic regression showed that Adipo-IR was an independent factor associated with frequent gout flares risk. The multivariate Cox regression analysis revealed that frequent gout flares and Adipo-IR were associated with NAFLD risk (HR: 7.88, 95% CI: 2.11-29.48, p < 0.01; HR: 1.058, 95% CI: 1.01-1.2, p < 0.05). And ROC showed that both of them had a great discriminant ability to diagnose NAFLD. Conclusions Our data showed an independent association between the frequency of gout flares or Adipo-IR and incident NAFLD. Frequent gout flares and elevated Adipo-IR had a good predictive capability towards NAFLD development and played a synergistic role in the development of NAFLD.
引用
收藏
页码:1389 / 1395
页数:7
相关论文
共 50 条
  • [31] Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
    Shun Ishido
    Nobuharu Tamaki
    Yuka Takahashi
    Naoki Uchihara
    Keito Suzuki
    Yuki Tanaka
    Haruka Miyamoto
    Michiko Yamada
    Hiroaki Matsumoto
    Tsubasa Nobusawa
    Taisei Keitoku
    Kenta Takaura
    Shohei Tanaka
    Chiaki Maeyashiki
    Yutaka Yasui
    Kaoru Tsuchiya
    Hiroyuki Nakanishi
    Masayuki Kurosaki
    Namiki Izumi
    BMC Gastroenterology, 23
  • [32] Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study
    Pang, Yuanjie
    Kartsonaki, Christiana
    Lv, Jun
    Millwood, Iona Y.
    Fairhurst-Hunter, Zammy
    Turnbull, Iain
    Bragg, Fiona
    Hill, Michael R.
    Yu, Canqing
    Guo, Yu
    Chen, Yiping
    Yang, Ling
    Clarke, Robert
    Walters, Robin G.
    Wu, Ming
    Chen, Junshi
    Li, Liming
    Chen, Zhengming
    Holmes, Michael, V
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2022, 115 (03): : 799 - 810
  • [33] Hepatitis B Virus Infection and Decreased Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
    Joo, Eun-Jeong
    Chang, Yoosoo
    Yeom, Joon-Sup
    Ryu, Seungho
    HEPATOLOGY, 2017, 65 (03) : 828 - 835
  • [34] Hepatitis B Virus Infection and Decreased Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
    Wang, Chia-Chi
    Kao, Jia-Horng
    HEPATOLOGY, 2017, 66 (02) : 681 - 681
  • [35] Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
    Dunn, Winston
    Xu, Ronghui
    Wingard, Deborah L.
    Rogers, Christopher
    Angulo, Paul
    Younossi, Zobair M.
    Schwimmer, Jeffrey B.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (09): : 2263 - 2271
  • [36] Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study
    Dunn, Winston
    Xu, Ronghui
    Wingard, Deborah L.
    Rogers, Christopher
    Angulo, Paul
    Younossi, Zobair M.
    Schwimmer, Jeffrey
    GASTROENTEROLOGY, 2008, 134 (04) : A781 - A782
  • [37] THE RISK OF LUNG CANCER IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Dahabra, Loai
    Abou Yassine, Ahmad
    Kassem, Ali
    Assaad, Marc
    Muhammad, Marwah
    Elsayegh, Dany E.
    CHEST, 2022, 162 (04) : 1621A - 1621A
  • [38] Choline intake in a large cohort of patients with nonalcoholic fatty liver disease
    Guerrerio, Anthony L.
    Colvin, Ryan M.
    Schwartz, Amy K.
    Molleston, Jean P.
    Murray, Karen F.
    Diehl, AnnaMae
    Mohan, Parvathi
    Schwimmer, Jeffrey B.
    Lavine, Joel E.
    Torbenson, Michael S.
    Scheimann, Ann O.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 95 (04): : 892 - 900
  • [39] High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study
    Bassegoda, Octavi
    Rivera-Esteban, Jesus
    Serra, Isabel
    Morillas, Rosa
    Broquetas, Teresa
    Vergara, Mercedes
    Rodriguez, Adria
    Aracil, Carles
    Viroles, Silvia
    Carrion, Jose A.
    Pardo, Albert
    Rodriguez-Tajes, Sergio
    Serra-Burriel, Miquel
    Pericas, Juan M.
    Augustin, Salvador
    Gines, Pere
    Graupera, Isabel
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (11) : 3212 - 3222
  • [40] Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease
    Fujii, Hideki
    Fujii, Makoto
    Iwaki, Michihiro
    Hayashi, Hideki
    Toyoda, Hidenori
    Oeda, Satoshi
    Hyogo, Hideyuki
    Kawanaka, Miwa
    Morishita, Asahiro
    Munekage, Kensuke
    Kawata, Kazuhito
    Tsutsumi, Tsubasa
    Sawada, Koji
    Maeshiro, Tatsuji
    Tobita, Hiroshi
    Yoshida, Yuichi
    Naito, Masafumi
    Araki, Asuka
    Arakaki, Shingo
    Kawaguchi, Takumi
    Noritake, Hidenao
    Ono, Masafumi
    Masaki, Tsutomu
    Yasuda, Satoshi
    Tomita, Eiichi
    Yoneda, Masato
    Kawada, Norifumi
    Tokushige, Akihiro
    Kamada, Yoshihiro
    Takahashi, Hirokazu
    Ueda, Shinichiro
    Aishima, Shinichi
    Sumida, Yoshio
    Nakajima, Atsushi
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2023, 53 (05) : 391 - 400